Increased ATF5 expression has been reported in aggressive chronic lymphocytic leukemia (57), follicular lymphoma (58), and childhood acute lymphoblastic leukemia (59), implying potential involvement of ATF5 in the tumorigenesis and progression of these hematopoietic malignancies. This evidence concerns the gene ATF5 and follicular lymphoma.